Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

As semiconductor devices continue to advance, the demand for reliable, high-performance test sockets has never been greater. Yet, traditional socket design validation methods—such as per-pin ...

Superannuation platforms may be gaming the annual performance test by handing back outsized fee rebates to customers so that laggard products do not face the consequences of failing the rigid ...

We just set out to see which NERF Loadout blasters deliver, and how to build the perfect setup for you and your squad. To find out, we turned Hypebeast HQ into a test arena and filmed an office ...

Psychology Today's online self-tests are intended for informational purposes only and are not diagnostic tools. Psychology Today does not capture or store personally identifiable information, and your ...

Cycling's governing body, the UCI, has today set out its position against the use of ketone supplements for the first time, saying it "sees no reason for them to be used" by professional cyclists.

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the ...

Unifying gravity and quantum theory remains a significant goal in modern physics. Despite the success in unifying all other fundamental interactions (electromagnetism, strong force and weak force) ...

Psychology Today's online self-tests are intended for informational purposes only and are not diagnostic tools. Psychology Today does not capture or store personally identifiable information, and your ...

Like clockwork, Apple has introduced a new M-series chip on updated versions of the iPad Pro, MacBook Pro and for the first time, Apple Vision Pro. The new M5 chip shares plenty of similarities with ...

Grail is on a mission to have its cancer blood test become a core part of U.S. screening for a range of tumors. Now, it’s detailing its latest data as it heads to the FDA. Back in June, Grail revealed ...